These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 9586613)
1. Transition zone index as a risk factor for acute urinary retention in benign prostatic hyperplasia. Kurita Y; Masuda H; Terada H; Suzuki K; Fujita K Urology; 1998 Apr; 51(4):595-600. PubMed ID: 9586613 [TBL] [Abstract][Full Text] [Related]
2. Prostate-specific antigen and transition zone index - powerful predictors for acute urinary retention in men with benign prostatic hyperplasia. Milonas D; Trumbeckas D Medicina (Kaunas); 2003; 39(11):1071-7. PubMed ID: 14646460 [TBL] [Abstract][Full Text] [Related]
3. Resistive index as risk factor for acute urinary retention in patients with benign prostatic hyperplasia. Shinbo H; Kurita Y; Takada S; Imanishi T; Otsuka A; Furuse H; Nakanishi T; Mugiya S; Ozono S Urology; 2010 Dec; 76(6):1440-5. PubMed ID: 20646746 [TBL] [Abstract][Full Text] [Related]
4. The utility of transition zone index in predicting acute urinary morbidity after 125I prostate brachytherapy. Crook J; Toi A; McLean M; Pond G Brachytherapy; 2002; 1(3):131-7. PubMed ID: 15090275 [TBL] [Abstract][Full Text] [Related]
5. Transrectal ultrasonography to predict the clinical outcome of transurethral microwave thermotherapy in patients with benign prostatic hyperplasia. Kurita Y; Ushiyama T; Suzuki K; Fujita K; Kawabe K Int J Urol; 1996 Nov; 3(6):448-53. PubMed ID: 9170571 [TBL] [Abstract][Full Text] [Related]
6. Ultrasonic measurement of bladder weight as a possible predictor of acute urinary retention in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Miyashita H; Kojima M; Miki T Ultrasound Med Biol; 2002 Aug; 28(8):985-90. PubMed ID: 12217433 [TBL] [Abstract][Full Text] [Related]
7. Significant changes in volume of seminal vesicles as determined by transrectal sonography in relation to age and benign prostatic hyperplasia. Hayakawa T; Naya Y; Kojima M Tohoku J Exp Med; 1998 Nov; 186(3):193-204. PubMed ID: 10348215 [TBL] [Abstract][Full Text] [Related]
8. Resistive index: a newly identified predictor of outcome of transurethral prostatectomy in patients with benign prostatic hyperplasia. Shinbo H; Kurita Y; Nakanishi T; Imanishi T; Otsuka A; Furuse H; Mugiya S; Ozono S Urology; 2010 Jan; 75(1):143-7. PubMed ID: 19854491 [TBL] [Abstract][Full Text] [Related]
9. The American Urological Association symptom index for benign prostatic hyperplasia as a function of age, volume and ultrasonic appearance of the prostate. Kojima M; Naya Y; Inoue W; Ukimura O; Watanabe M; Saitoh M; Watanabe H J Urol; 1997 Jun; 157(6):2160-5. PubMed ID: 9146607 [TBL] [Abstract][Full Text] [Related]
10. Transrectal ultrasonic planimetry of the prostate in relation to age and lower urinary tract symptoms among elderly men in Japan. Taneike R; Kojima M; Saitoh M Tohoku J Exp Med; 1997 Oct; 183(2):135-50. PubMed ID: 9526804 [TBL] [Abstract][Full Text] [Related]
11. Transrectal ultrasound parameters: presumed circle area ratio and transitional zone area in the evaluation of patients with lower urinary tract symptoms. Desai MM J Endourol; 1999 May; 13(4):317-21. PubMed ID: 10405914 [TBL] [Abstract][Full Text] [Related]
12. Role of Doppler ultrasound and resistive index in benign prostatic hypertrophy. Tsuru N; Kurita Y; Masuda H; Suzuki K; Fujita K Int J Urol; 2002 Aug; 9(8):427-30. PubMed ID: 12225338 [TBL] [Abstract][Full Text] [Related]
13. Identifying the predictors of acute urinary retention following magnetic-resonance-guided prostate brachytherapy. Thomas MD; Cormack R; Tempany CM; Kumar S; Manola J; Schneider L; Hurwitz MD; D'Amico AV Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):905-8. PubMed ID: 10863058 [TBL] [Abstract][Full Text] [Related]
14. Urinary bladder characteristics via ultrasound as predictors of acute urinary retention in men with benign prostatic hyperplasia. Ho CC; Ngoo KS; Hamzaini AH; Rizal AM; Zulkifli MZ Clin Ter; 2014; 165(2):75-81. PubMed ID: 24770808 [TBL] [Abstract][Full Text] [Related]
15. Total prostate and transition zone volumes, and transition zone index are poorly correlated with objective measures of clinical benign prostatic hyperplasia. Lepor H; Nieder A; Feser J; O'Connell C; Dixon C J Urol; 1997 Jul; 158(1):85-8. PubMed ID: 9186329 [TBL] [Abstract][Full Text] [Related]
16. [Transition zone index in predicting therapeutic efficacy of benign prostatic hyperplasia]. Otani T; Fujimoto K; Yoshida K; Ozono S; Hirao Y; Okajima E; Hayashi Y; Kurumatani N Nihon Hinyokika Gakkai Zasshi; 2002 Jan; 93(1):20-7. PubMed ID: 11842535 [TBL] [Abstract][Full Text] [Related]
17. Transition zone volume and transition zone ratio: predictor of uroflow response to finasteride therapy in benign prostatic hyperplasia patients. Tewari A; Shinohara K; Narayan P Urology; 1995 Feb; 45(2):258-64; discussion 265. PubMed ID: 7531900 [TBL] [Abstract][Full Text] [Related]
18. Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group. Roehrborn CG; McConnell JD; Lieber M; Kaplan S; Geller J; Malek GH; Castellanos R; Coffield S; Saltzman B; Resnick M; Cook TJ; Waldstreicher J Urology; 1999 Mar; 53(3):473-80. PubMed ID: 10096369 [TBL] [Abstract][Full Text] [Related]
19. The correlation between prostate volume, transition zone volume, transition zone index and clinical and urodynamic investigations in patients with lower urinary tract symptoms. Witjes WP; Aarnink RG; Ezz-el-Din K; Wijkstra H; Debruyne EM; de la Rosette JJ Br J Urol; 1997 Jul; 80(1):84-90. PubMed ID: 9240186 [TBL] [Abstract][Full Text] [Related]
20. Transition zone ratio and prostate-specific antigen density: the index of response of benign prostatic hypertrophy to an alpha blocker. Kurita Y; Ushiyama T; Suzuki K; Fujita K; Kawabe K Int J Urol; 1996 Sep; 3(5):361-6. PubMed ID: 8886912 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]